PT98921A - Metodo de tratamento de perturbacoes respiratorias em seres humanos ou animais, mediante a administracao de uma composicao compreendendo um derivado de naftaleno especifico - Google Patents

Metodo de tratamento de perturbacoes respiratorias em seres humanos ou animais, mediante a administracao de uma composicao compreendendo um derivado de naftaleno especifico Download PDF

Info

Publication number
PT98921A
PT98921A PT98921A PT9892191A PT98921A PT 98921 A PT98921 A PT 98921A PT 98921 A PT98921 A PT 98921A PT 9892191 A PT9892191 A PT 9892191A PT 98921 A PT98921 A PT 98921A
Authority
PT
Portugal
Prior art keywords
carbon atoms
symptoms
added
pharmaceutically acceptable
quot
Prior art date
Application number
PT98921A
Other languages
English (en)
Portuguese (pt)
Inventor
James Vincent Sorrentino
Donald Kay Riker
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of PT98921A publication Critical patent/PT98921A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT98921A 1990-09-11 1991-09-10 Metodo de tratamento de perturbacoes respiratorias em seres humanos ou animais, mediante a administracao de uma composicao compreendendo um derivado de naftaleno especifico PT98921A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58072990A 1990-09-11 1990-09-11

Publications (1)

Publication Number Publication Date
PT98921A true PT98921A (pt) 1992-07-31

Family

ID=24322297

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98921A PT98921A (pt) 1990-09-11 1991-09-10 Metodo de tratamento de perturbacoes respiratorias em seres humanos ou animais, mediante a administracao de uma composicao compreendendo um derivado de naftaleno especifico

Country Status (7)

Country Link
AU (1) AU8505991A (xx)
EG (1) EG19841A (xx)
IE (1) IE913184A1 (xx)
MA (1) MA22278A1 (xx)
MX (1) MX9101031A (xx)
PT (1) PT98921A (xx)
WO (1) WO1992004022A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255639B (it) * 1992-07-30 1995-11-09 Uso dell'oxatomide come agente antitosse
US5626831A (en) * 1995-12-20 1997-05-06 Van Moerkerken; Arthur Method for relief and prevention of common cold, and compositions
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
JP2002523358A (ja) * 1998-08-25 2002-07-30 プラット，クリス ナプロキセンおよびプソイドエフェドリンを含む徐法性錠剤
CL2003002653A1 (es) 2002-12-18 2005-04-22 Wyeth Corp Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
US20050192355A1 (en) * 2004-02-17 2005-09-01 Wyeth Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
WO2016063055A1 (en) * 2014-10-21 2016-04-28 Reckitt Benckiser Llc Pharmaceutical capsule containing at least two tablets
EP3364955B1 (en) * 2015-10-09 2022-04-20 RB Health (US) LLC Pharmaceutical formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7503081A (nl) * 1974-03-21 1975-09-23 Hoechst Ag Werkwijze voor het bereiden van een gemengde katalysator.
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs

Also Published As

Publication number Publication date
WO1992004022A1 (en) 1992-03-19
IE913184A1 (en) 1992-03-11
MX9101031A (es) 1992-05-04
AU8505991A (en) 1992-03-30
EG19841A (en) 1996-03-31
MA22278A1 (fr) 1992-04-01

Similar Documents

Publication Publication Date Title
WO1995007103A1 (en) Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
CA2146637C (en) Pharmaceutical compositions and methods for treating cold symptoms
CA2247500A1 (en) Caffeine and clemastine for treating respiratory disorders
JP2018135372A (ja) ロキソプロフェン又はその塩含有の医薬組成物＜３＞
JP5542309B2 (ja) 経口医薬組成物
PT98921A (pt) Metodo de tratamento de perturbacoes respiratorias em seres humanos ou animais, mediante a administracao de uma composicao compreendendo um derivado de naftaleno especifico
US6995190B2 (en) Method and treatment with ketoprofen solution
WO1995007079A1 (en) Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
EP0674527A1 (en) Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
JP5952944B2 (ja) ロキソプロフェン又はその塩含有の医薬組成物そのｉｉ
JPH11510168A (ja) 呼吸障害を処理するための鎮痛剤及び抗ヒスタミン剤を含有する組成物及び方法
JP5232520B2 (ja) ロキソプロフェンを含有する抗アデノウイルス剤
JP2008115168A (ja) 抗アデノウイルス剤
JP5993498B2 (ja) ロキソプロフェン又はその塩を含有する医薬組成物その弐
JP2017132819A (ja) ロキソプロフェン又はその塩含有の医薬組成物
CA2090234C (en) Method for providing improved analgesic effect
AU5899394A (en) Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen
GB2244645A (en) Oral compositions for treating cough
JP5898964B2 (ja) ロキソプロフェン又はその塩を含有する医薬組成物
US20060147481A1 (en) Ketoprofen powder for oral use
JP2016027022A (ja) 医薬組成物

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920330

FC3A Refusal

Effective date: 19981109